Cognizant Collaborates with Alnylam as Technology Services Partner to Scale IT Operations
Cognizant (CTSH) has announced a new IT Managed Services partnership with Alnylam Pharmaceuticals, a leading RNAi therapeutics company. As the primary IT services provider, Cognizant will manage Alnylam's global infrastructure, operations, cloud, security, platforms, applications, and advanced data analytics. The collaboration aims to enhance automation, reduce operational efforts, and improve business decision transparency using Cognizant's managed services frameworks and tools. This partnership leverages Cognizant's experience working with 30 top global pharmaceutical companies to implement and manage advanced technology solutions.
Cognizant (CTSH) ha annunciato una nuova partnership per i servizi IT gestiti con Alnylam Pharmaceuticals, un'azienda leader nel settore delle terapie RNAi. In qualità di principale fornitore di servizi IT, Cognizant gestirà l'infrastruttura globale, le operazioni, il cloud, la sicurezza, le piattaforme, le applicazioni e l'analisi dei dati avanzata di Alnylam. La collaborazione mira a migliorare l'automazione, ridurre gli sforzi operativi e aumentare la trasparenza nelle decisioni aziendali utilizzando i framework e gli strumenti di servizi gestiti di Cognizant. Questa partnership sfrutta l'esperienza di Cognizant nel lavorare con 30 delle principali aziende farmaceutiche globali per implementare e gestire soluzioni tecnologiche avanzate.
Cognizant (CTSH) ha anunciado una nueva asociación de Servicios IT Gestionados con Alnylam Pharmaceuticals, una empresa líder en terapias de RNAi. Como proveedor principal de servicios IT, Cognizant gestionará la infraestructura global, las operaciones, la nube, la seguridad, las plataformas, las aplicaciones y el análisis de datos avanzado de Alnylam. La colaboración tiene como objetivo mejorar la automatización, reducir los esfuerzos operativos y mejorar la transparencia en la toma de decisiones empresariales utilizando los marcos y herramientas de servicios gestionados de Cognizant. Esta asociación aprovecha la experiencia de Cognizant al trabajar con 30 de las principales empresas farmacéuticas globales para implementar y gestionar soluciones tecnológicas avanzadas.
코그니잔트 (CTSH)는 RNAi 치료제 분야의 선두주자인 알닐람 제약과 새로운 IT 관리 서비스 파트너십을 발표했습니다. 코그니잔트는 주요 IT 서비스 제공업체로서 알닐람의 글로벌 인프라, 운영, 클라우드, 보안, 플랫폼, 애플리케이션 및 고급 데이터 분석을 관리할 것입니다. 이번 협력은 자동화를 향상시키고 운영 노력을 줄이며, 코그니잔트의 관리 서비스 프레임워크와 도구를 사용하여 비즈니스 결정의 투명성을 개선하는 것을 목표로 하고 있습니다. 이 파트너십은 30개의 주요 글로벌 제약회사와의 협력을 통한 코그니잔트의 경험을 바탕으로 고급 기술 솔루션을 구현하고 관리합니다.
Cognizant (CTSH) a annoncé un nouveau partenariat en services informatiques gérés avec Alnylam Pharmaceuticals, un leader dans le domaine des thérapies RNAi. En tant que principal fournisseur de services informatiques, Cognizant gérera l'infrastructure mondiale, les opérations, le cloud, la sécurité, les plateformes, les applications et l'analyse de données avancée d'Alnylam. La collaboration vise à améliorer l'automatisation, à réduire les efforts opérationnels et à améliorer la transparence des décisions d'affaires en utilisant les cadres et outils de services gérés de Cognizant. Ce partenariat tirera parti de l'expérience de Cognizant auprès de 30 des principales entreprises pharmaceutiques mondiales pour mettre en œuvre et gérer des solutions technologiques avancées.
Cognizant (CTSH) hat eine neue Partnerschaft für verwaltete IT-Dienste mit Alnylam Pharmaceuticals, einem führenden Unternehmen im Bereich RNAi-Therapien, angekündigt. Als Hauptanbieter von IT-Diensten wird Cognizant die globale Infrastruktur, die Betriebsabläufe, die Cloud, die Sicherheit, die Plattformen, die Anwendungen und die fortgeschrittene Datenanalyse von Alnylam verwalten. Das Ziel der Zusammenarbeit ist es, die Automatisierung zu verbessern, den operativen Aufwand zu reduzieren und die Transparenz von Geschäftsentscheidungen mithilfe der verwalteten Dienstleistungsrahmen und -tools von Cognizant zu erhöhen. Diese Partnerschaft nutzt die Erfahrung von Cognizant, die sie bei der Zusammenarbeit mit 30 der weltweit führenden Pharmaunternehmen gesammelt haben, um fortschrittliche Technologielösungen zu implementieren und zu verwalten.
- Strategic partnership with a leading biopharmaceutical company expanding Cognizant's life sciences portfolio
- Addition of comprehensive IT services contract covering multiple technology areas
- Strengthens position in pharmaceutical sector where Cognizant already serves 30 top global companies
- None.
Insights
This strategic IT partnership marks a significant expansion of Cognizant's footprint in the lucrative pharmaceutical sector. The deal encompasses comprehensive IT services including infrastructure, cloud, security and advanced analytics - representing a substantial long-term revenue stream. While specific financial terms aren't disclosed, enterprise-wide IT management contracts with major pharma companies typically generate
The partnership strengthens Cognizant's position in the life sciences vertical, where it already serves 30 of the top global pharmaceutical companies. The focus on AI and automation aligns with high-margin next-gen IT services, potentially improving profit margins. For investors, this demonstrates Cognizant's continued ability to win large, strategic deals in a competitive market while expanding its healthcare/pharma portfolio, which typically offers better margins than traditional IT services.
Utilizing Cognizant's top-tier managed services frameworks and tools, the partnership aims to enhance Alnylam's automation and reduce operational efforts
Cognizant has been selected as the technology partner responsible for managing Alnylam's global infrastructure and operations, cloud, security, platforms, applications, and advanced data analytics. Leveraging Cognizant's managed services frameworks and tools, the collaboration aims to improve automation, reduce operational efforts, and ensure transparency in business decisions and unified performance accountability.
"By leveraging Cognizant's expertise in the life sciences sector and innovative managed services frameworks, we will aim to accelerate our business outcomes and ultimately improve customer experiences," said Larry Egan, Vice President of Strategic Technologies at Alnylam.
Thirty of the top global pharmaceutical companies work with Cognizant to implement and manage advanced technology solutions, enabling them to bring their innovative drugs to market, run global supply chains and manufacturing systems, and comply with complex regulations.
"We are thrilled to partner with Alnylam on its IT transformation journey," said Cognizant's Mohammad Haque, SVP, Global Large Deals Lead and BU Head, Life Sciences. "We will bring our extensive experience with large pharmaceutical companies, along with investments in AI, to accelerate Alnylam's business goals. As a strategic partner, we look forward to helping Alnylam grow its business and continue delivering transformative medicines to treat both rare and prevalent diseases."
About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we're improving everyday life. See how at www.cognizant.com or @cognizant.
Contact:
Natalie Steffen
Natalie.Steffen@cognizant.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cognizant-collaborates-with-alnylam-as-technology-services-partner-to-scale-it-operations-302290305.html
SOURCE Cognizant Technology Solutions
FAQ
What services will Cognizant (CTSH) provide to Alnylam Pharmaceuticals?
How many pharmaceutical companies does Cognizant (CTSH) currently work with?
What are the main objectives of the Cognizant (CTSH) and Alnylam partnership?
